Anna Fakadej, MD
Ophthalmology · Southern Pines, NCNPI 1932190261
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $12,395 of the $17,909 with a category attached, or 69.2%. Alcon accounts for 91.0% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2022 at $10,927 and has fallen 62.2% since, to $4,135 in 2025. Among ophthalmology clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 77 payments — averaging $232.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$16K
- Alcon Research LLC$980
- Rxsight Inc$174
- Biotissue Holdings Inc.$162
- Glaukos Corporation$108
- Johnson & Johnson Surgical Vision, Inc.$101
- plus $88 from 4 others
Across 521 payments — averaging $546.87 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Alcon Research LLC$202K
- Kala Pharmaceuticals, Inc.$69K
- Bausch Health US, LLC$14K
What the payments were for
- Consulting fees$2,94016%
- Speaking & faculty fees$12,39569%
- Travel & lodging$1751%
- Food & beverage$2,39913%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 54 | $16,296 |
| Alcon Research LLC | 2 | $980 |
| Rxsight Inc | 3 | $174 |
| Biotissue Holdings Inc. | 9 | $162 |
| Glaukos Corporation | 3 | $108 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $101 |
| Bausch & Lomb Americas Inc. | 2 | $44 |
| AbbVie | 1 | $16 |
| Ivantis, Inc | 1 | $14 |
| Rayner Intraocular Lenses Limited | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Clareon$14,530
- Hydrus Microstent$145
- DAILIES TOTAL1$125
- Tecnis Simplicity$101
- TOTAL30$100
How this compares
$17,909 in reported general payments places this provider in the 90th percentile of 588 ophthalmology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 828 | $29,655 |
| Difluprednate | 255 | $26,627 |
| Ofloxacin | 1,133 | $13,252 |
| Brimonidine Tartrate | 20 | $431 |
| Timolol Maleate | 55 | $423 |
| Gentamicin Sulfate | 54 | $401 |
| Latanoprost | 38 | $304 |
| Ketorolac Tromethamine | 13 | $245 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Southern Pines
- Arghavan AlmonySouthern Pines$87K
- Winston GarrisSouthern Pines$10K
- Robert SharpeSouthern Pines$8K
- Preeya GuptaRaleigh$1.8M
- Julie WoodwardDurham$1M
- Rajiv ShahWinston Salem$909K
- Lejla VajzovicDurham$681K
- Karl StonecipherGreensboro$653K
- Terry KimDurham$605K
- Keith WalterWinston Salem$397K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.